berberine has been researched along with Cognitive Dysfunction in 18 studies
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To give an overview of the therapeutic potential of berberine as a treatment for dementia associated with diabetes." | 9.05 | Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. ( Bell, J; Bligh, A; Katsuno, T; Parkinson, J; Shinjyo, N, 2020) |
| "The results showed that administration of berberine for 6 months significantly improved cognitive deficits and insulin resistance in naturally aging rats (p<0." | 7.88 | Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats. ( Chen, L; Guan, F; Guan, Y; Li, J; Lv, X; Teng, F; Xu, J; Yu, Y; Zhang, M; Zhao, Y, 2018) |
| "Berberine is a natural isoquinoline alkaloid isolated from the Rhizoma coptidis." | 5.56 | Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance. ( Chen, H; Chen, Y; Huang, M; Ji, X; Liang, Y, 2020) |
| "Berberine (BBR) is a herbal alkaloid, which shows many neuroprotective properties in neurodegenerative diseases." | 5.51 | Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia. ( Bashiri, H; Ghotbi Ravandi, S; Khodamoradi, M; Nozari, M; Saeedi Goraghani, M; Shabani, M, 2019) |
| "Berberine is an isoquinoline alkaloid extracted from the Chinese herb, Coptis rhizome, which exhibits numerous biological effects on gastrointestinal disorders." | 5.48 | Cognitive impairments induced by severe acute pancreatitis are attenuated by berberine treatment in rats. ( Gong, C; Hua, Y; Kang, Y; Liao, X; Ou, X, 2018) |
| "Berberine (BBR) plays an important role in the prevention and treatment of Alzheimer's disease (AD)." | 5.46 | Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation. ( Cai, Z; Chen, Y; He, W; He, Y; Wang, C, 2017) |
| "To give an overview of the therapeutic potential of berberine as a treatment for dementia associated with diabetes." | 5.05 | Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. ( Bell, J; Bligh, A; Katsuno, T; Parkinson, J; Shinjyo, N, 2020) |
| " Berberine has demonstrated good neuroprotective effects in models of acute cerebral ischemia; however, whether it can alleviate cognitive impairment caused by chronic cerebral hypoperfusion has rarely been investigated." | 4.12 | Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in Rats. ( Du, Y; Huang, Y; Li, F; Luo, Y; Tao, Z; Tian, Y; Wang, N; Wang, Q; Wang, Y; Yan, F; Zhao, F; Zheng, Y, 2022) |
| "The results showed that administration of berberine for 6 months significantly improved cognitive deficits and insulin resistance in naturally aging rats (p<0." | 3.88 | Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats. ( Chen, L; Guan, F; Guan, Y; Li, J; Lv, X; Teng, F; Xu, J; Yu, Y; Zhang, M; Zhao, Y, 2018) |
| "Berberine (BBR) is an isoquinoline alkaloid extracted from various berberine species." | 2.82 | A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment. ( Devi, B; Sahu, K; Singh, A; Singh, C; Singh, S, 2022) |
| "Berberine treatment attenuates hippocampal insulin resistance and improves cognitive function." | 1.91 | Simulated weightlessness induces hippocampal insulin resistance and cognitive impairment. ( Chen, J; Dong, L; Gao, F; Kou, Z; Kuang, F; Li, G; Li, J; Xue, C; Yang, H; Zhang, J; Zhang, S; Zhang, X, 2023) |
| "Berberine was used to uncover the mechanisms for the treatment of hyperinsulinemia in IR model." | 1.62 | Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway. ( Bao, Y; Chen, Q; Han, Y; Liu, C; Liu, W; Liu, X; Wang, J; Wu, N; Ye, Y; Yu, Y, 2021) |
| "Berberine is a natural isoquinoline alkaloid isolated from the Rhizoma coptidis." | 1.56 | Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance. ( Chen, H; Chen, Y; Huang, M; Ji, X; Liang, Y, 2020) |
| "Berberine (BBR) is a herbal alkaloid, which shows many neuroprotective properties in neurodegenerative diseases." | 1.51 | Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia. ( Bashiri, H; Ghotbi Ravandi, S; Khodamoradi, M; Nozari, M; Saeedi Goraghani, M; Shabani, M, 2019) |
| "Berberine is an isoquinoline alkaloid extracted from the Chinese herb, Coptis rhizome, which exhibits numerous biological effects on gastrointestinal disorders." | 1.48 | Cognitive impairments induced by severe acute pancreatitis are attenuated by berberine treatment in rats. ( Gong, C; Hua, Y; Kang, Y; Liao, X; Ou, X, 2018) |
| "Berberine (BBR) plays an important role in the prevention and treatment of Alzheimer's disease (AD)." | 1.46 | Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation. ( Cai, Z; Chen, Y; He, W; He, Y; Wang, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 10 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, Y | 2 |
| Zheng, Y | 2 |
| Wang, Q | 1 |
| Yan, F | 2 |
| Tao, Z | 1 |
| Zhao, F | 2 |
| Wang, Y | 2 |
| Huang, Y | 1 |
| Li, F | 2 |
| Du, Y | 1 |
| Wang, N | 2 |
| Luo, Y | 2 |
| Sahu, K | 1 |
| Singh, S | 1 |
| Devi, B | 1 |
| Singh, C | 1 |
| Singh, A | 1 |
| Wang, R | 1 |
| Yang, M | 1 |
| Wang, J | 2 |
| Li, J | 3 |
| Xue, C | 1 |
| Yang, H | 1 |
| Zhang, J | 1 |
| Li, G | 1 |
| Kuang, F | 1 |
| Chen, J | 1 |
| Zhang, S | 1 |
| Gao, F | 1 |
| Kou, Z | 1 |
| Zhang, X | 1 |
| Dong, L | 1 |
| Wang, RH | 1 |
| Zhou, R | 1 |
| Ding, Y | 1 |
| Zhou, ZX | 1 |
| Chen, Y | 4 |
| Liang, Y | 3 |
| Chen, H | 2 |
| Ji, X | 2 |
| Huang, M | 3 |
| Shinjyo, N | 1 |
| Parkinson, J | 1 |
| Bell, J | 1 |
| Katsuno, T | 1 |
| Bligh, A | 1 |
| Wu, N | 1 |
| Liu, W | 1 |
| Han, Y | 1 |
| Ye, Y | 1 |
| Liu, X | 1 |
| Yu, Y | 2 |
| Chen, Q | 1 |
| Bao, Y | 1 |
| Liu, C | 1 |
| Ye, C | 1 |
| Xiong, Y | 1 |
| She, Y | 1 |
| Zhong, X | 1 |
| Zhang, JH | 1 |
| Zhang, JF | 1 |
| Song, J | 1 |
| Bai, Y | 1 |
| Deng, L | 1 |
| Feng, CP | 1 |
| Xu, XY | 1 |
| Guo, HX | 1 |
| Gao, X | 1 |
| Gu, Y | 1 |
| Jin, C | 1 |
| Zheng, JF | 1 |
| Zhen, Z | 1 |
| Su, H | 1 |
| He, W | 1 |
| Wang, C | 1 |
| He, Y | 1 |
| Cai, Z | 1 |
| Zhao, Y | 1 |
| Teng, F | 1 |
| Guan, Y | 1 |
| Xu, J | 2 |
| Lv, X | 1 |
| Guan, F | 1 |
| Zhang, M | 1 |
| Chen, L | 1 |
| Ou, X | 1 |
| Hua, Y | 1 |
| Liao, X | 1 |
| Gong, C | 1 |
| Kang, Y | 1 |
| Ghotbi Ravandi, S | 1 |
| Shabani, M | 1 |
| Bashiri, H | 1 |
| Saeedi Goraghani, M | 1 |
| Khodamoradi, M | 1 |
| Nozari, M | 1 |
| Liu, P | 1 |
| Li, Y | 1 |
| Qi, X | 1 |
| Liu, D | 1 |
| Chi, T | 1 |
| Liu, H | 1 |
| Zou, L | 1 |
| Zhang, Z | 1 |
| Li, X | 1 |
| An, L | 1 |
| Jiang, X | 1 |
| Liu, Q | 1 |
| Chen, S | 1 |
| Guo, Y | 1 |
2 reviews available for berberine and Cognitive Dysfunction
| Article | Year |
|---|---|
A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Topics: Berberine; Chemotherapy-Related Cognitive Impairment; Cognitive Dysfunction; Humans; Neuroprotective | 2022 |
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Berberine; Brain; Cholinergic Agonists; Cognitive Dysfunct | 2020 |
16 other studies available for berberine and Cognitive Dysfunction
| Article | Year |
|---|---|
Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in Rats.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Brain Ischemia; Carotid Artery, Common; Cognitive Dysf | 2022 |
Berberine protects against chronic cerebral hypoperfusion-induced cognitive impairment and hippocampal damage via regulation of the ERK/Nrf2 pathway.
Topics: Animals; Berberine; Brain Ischemia; Cognitive Dysfunction; Hippocampus; MAP Kinase Signaling System; | 2022 |
Berberine Ameliorates Cognitive Disorder via GSK3β/PGC-1α Signaling in APP/PS1 Mice.
Topics: Alzheimer Disease; Animals; Berberine; Cognition; Cognitive Dysfunction; Cytokines; Disease Models, | 2022 |
Simulated weightlessness induces hippocampal insulin resistance and cognitive impairment.
Topics: Animals; Berberine; Cognitive Dysfunction; Hippocampus; Insulin; Insulin Resistance; Memory Disorder | 2023 |
[Effects of berberine on learning and memory ability in vascular cognitive impairment rats].
Topics: Animals; Berberine; Cognitive Dysfunction; Hippocampus; Inflammation; Maze Learning; Memory; Oxidati | 2019 |
Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Topics: Alzheimer Disease; Animals; Autophagy; Beclin-1; Berberine; Cathepsin D; Cells, Cultured; Cognitive | 2020 |
Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.
Topics: Amyloid beta-Peptides; Animals; Berberine; Cell Line, Tumor; Cognitive Dysfunction; Diabetes Mellitu | 2021 |
Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Berberine; Brain; Cerebrovascular Circ | 2021 |
Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action.
Topics: Animals; Apoptosis; Berberine; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diet, High-Fa | 2021 |
Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation.
Topics: Alzheimer Disease; Animals; Berberine; Biomarkers; Blotting, Western; Cognitive Dysfunction; Glutath | 2017 |
Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Berberine; Cognition; Cognitive Dysfunction; Diet, Hi | 2018 |
Cognitive impairments induced by severe acute pancreatitis are attenuated by berberine treatment in rats.
Topics: Acute Disease; Animals; Apoptosis; Berberine; Blood-Brain Barrier; Cognition; Cognitive Dysfunction; | 2018 |
Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia.
Topics: Animals; Animals, Newborn; Berberine; Cognitive Dysfunction; Disease Models, Animal; Dizocilpine Mal | 2019 |
Protein kinase C is involved in the neuroprotective effect of berberine against intrastriatal injection of quinolinic acid-induced biochemical alteration in mice.
Topics: Animals; Berberine; Cognitive Dysfunction; Disease Models, Animal; Glutamic Acid; Glycogen Synthase | 2019 |
Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice.
Topics: Aged; Aging; Animals; Anti-Inflammatory Agents; Berberine; Calcium-Binding Proteins; Cell Line; Cogn | 2016 |
Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2017 |